Antitubercular Drug Development: Current Status and Research Strategies

Author(s): Kuldipsinh P. Barot, Stoyanka Nikolova, Illiyan Ivanov, Manjunath D. Ghate

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 13 , Issue 11 , 2013

Become EABM
Become Reviewer
Call for Editor


Recent developments and novel research strategies are adopted widely to discover and develop the new drugs to treat tuberculosis. New antitubercular drugs are urgently needed because tuberculosis remains a global health problem as around nine million new cases are estimated each year with almost two million fatalities. It states the impact and outcomes that have made a significant effect in antitubercular drug development. We are presenting current status of tuberculosis, antitubercular drug development, novel molecular targets, novel agents in clinical and pre-clinical development and some efforts that are being made in the development of novel molecules based on different pharmacophores as lead compounds and recent strategies.

Keywords: Tuberculosis, molecular targets, novel agents in evaluation phase, novel antitubercular agents, novel heterocyclic molecules.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Page: [1664 - 1684]
Pages: 21
DOI: 10.2174/13895575113139990076
Price: $65

Article Metrics

PDF: 11